Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

4.4K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

915
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
915
Teratogenicity01:07

Teratogenicity

4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

398
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
398
Cholecystitis01:20

Cholecystitis

3
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
3
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-Onset Sepsis in Preterm Neonates of 22-28 Weeks' Gestation: An International Cohort Study.

Journal of pediatrics. Clinical practice·2026
Same author

Totally Percutaneous Fetoscopic Repair of Open Spina Bifida: A Single-Center Experience with Perinatal, Obstetric, and Early Functional Outcomes.

Journal of clinical medicine·2026
Same author

Variation in Stabilization and Resuscitation Practices at Birth of Preterm Infants Among 12 National or Regional Neonatal Networks.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Oxygen saturation targeting and retinopathy management in very preterm neonates: An international survey.

Neonatology·2026
Same author

Rehospitalization in Preterm Infants: Machine Learning Prediction Model and Associated Risk Factors.

Neonatology·2026
Same author

Healthcare Professionals' Availability for Management of Preterm Neonates < 29 Weeks' Gestation in 12 iNeo Neonatal Networks.

Neonatology·2026
Same journal

A Renewed Call to Action for Breastfeeding Support: Let's Collaborate.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same journal

Improving Access to Hospital-Grade Breast Pumps for Women with Infants in the Neonatal Intensive Care Unit.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same journal

Examining Relationships Between Multiple Adverse Social Determinants of Health, Maternal Depressive Symptoms, Timing of Solid Food Introduction, and Breastfeeding Duration Among Black or African American Women.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same journal

Letter to the Editor Regarding "Impact of Oromotor Stimulation on Transition from Gavage to Full Oral Feeding in Preterm Neonates: A Randomized Controlled Trial".

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same journal

Impact of Integrated Continuous Team Midwifery Care on Breastfeeding Success within the Iranian Health System: A Randomized Controlled Trial.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same journal

A Full Plate-Reflections from an ABM Founder.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

850

Colchicine use during breastfeeding.

Tina Herscovici1, Paul Merlob, Bracha Stahl

  • 11 Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel , Petah Tiqva, Israel .

Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine
|February 4, 2015
PubMed
Summary
This summary is machine-generated.

Breastfeeding mothers using colchicine showed no increased risk of adverse outcomes in their infants. This study supports continuing breastfeeding while taking colchicine.

More Related Videos

How to Create Conditioned Taste Aversion for Grazing Ground Covers in Woody Crops with Small Ruminants
05:55

How to Create Conditioned Taste Aversion for Grazing Ground Covers in Woody Crops with Small Ruminants

Published on: April 30, 2016

7.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

850
How to Create Conditioned Taste Aversion for Grazing Ground Covers in Woody Crops with Small Ruminants
05:55

How to Create Conditioned Taste Aversion for Grazing Ground Covers in Woody Crops with Small Ruminants

Published on: April 30, 2016

7.8K

Area of Science:

  • Perinatology
  • Neonatology
  • Pharmacology

Background:

  • Colchicine is used for various conditions, including gout and familial Mediterranean fever.
  • Information on the safety of colchicine use during lactation is limited.
  • Evaluating infant outcomes is crucial for guiding clinical recommendations.

Purpose of the Study:

  • To assess the safety and outcomes of infants exposed to colchicine through breast milk.
  • To provide evidence-based guidance for breastfeeding mothers taking colchicine.

Main Methods:

  • Prospective observational cohort study design.
  • 37 mothers breastfeeding while taking colchicine and their infants were compared to 76 control infants.
  • Infant outcomes, including symptoms and development, were monitored for 1-3 years.

Main Results:

  • No significant difference in adverse neonatal symptoms between colchicine-exposed and control infants (p=0.68).
  • Similar rates of delayed development or neurological abnormalities in both groups (p=0.60).
  • No abnormal growth was observed in colchicine-exposed infants.

Conclusions:

  • Breastfeeding while taking colchicine does not appear to increase adverse long-term infant outcomes.
  • Data support the continuation of breastfeeding for mothers treated with colchicine.